Applied DNA Sciences Inc (APDN): My personal experience at Sloan Ketterin...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	13
Posts	2189
Boards Moderated	0
Alias Born	08/18/2012

yip

Re: Parkmart post# 55681

Monday, 04/29/2019 3:01:55 PM

Monday, April 29, 2019 3:01:55 PM

My personal experience at Sloan Kettering and Immuno-Therapy drugs like Keytruda, while disturbing, lead me to believe the potential market is huge...

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent APDN News

Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/04/2024 10:18:33 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/12/2024 09:25:36 PM
Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/12/2024 09:09:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:05:22 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/08/2024 09:01:31 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/01/2024 09:05:28 PM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:24:06 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/10/2024 10:16:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:00:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:05:23 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/07/2023 09:01:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:05:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 10:09:34 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/07/2023 10:02:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 08:05:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:05:45 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:01:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 08:02:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 09:04:44 PM
Applied DNA to Report Second Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, May 11, 2023 • Business Wire • 05/03/2023 07:00:00 PM

More APDN News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover